State University of New York at Buffalo: Sclerosis trials
The registry lists 11 Sclerosis studies with State University of New York at Buffalo as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 2 3Phase 3 3Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple SclerosisTerminatedNCT04925557Phase 2/3Results posted
- Natalizumab in Preventing Post-partum Relapses in Multiple SclerosisCompletedNCT03046251Phase 4Results posted
- Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple SclerosisCompletedNCT02651545Results posted
- Effects of Acthar on Recovery From Cognitive Relapses in MSCompletedNCT02290444Phase 3Results posted
- Effects of Dalfampridine on Cognition in Multiple SclerosisCompletedNCT02006160Phase 2/3Results posted
- Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple SclerosisCompletedNCT01615887Phase 2Results posted
- Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSECompletedNCT01450072Not applicableResults posted
- Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical)CompletedNCT05974839
- Technology-assisted Conscientiousness Therapy for People With Multiple SclerosisCompletedNCT04953689Not applicable
- Impact of Brain Connectome and Personality on Cognitive Rehabilitation in Multiple SclerosisCompletedNCT03306875Not applicable
- Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MSCompletedNCT00463710